| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 2e-05 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0005 |